B

BranchLab

AI-driven healthcare ad targeting with privacy

Client Success Manager

Full-TimeUpdated on 10/4/2026
$85k - $150k/yr+ Equity opportunities
Mid
Bachelor's
New York, NY, USA
Hybrid
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in a related field is required.
  • Proven experience in client-facing roles such as account management, customer success, or sales is required.
  • The ability to build rapport and trust with clients through communication and interpersonal skills is required.
  • Strong problem-solving abilities and a proactive, solution-oriented mindset are required.
  • The ability to manage multiple clients and priorities simultaneously with organizational skills is required.
  • The ability to work in a fast-paced, high-growth environment while balancing strategic vision with execution is required.
Responsibilities
  • Own relationships with pharmaceutical manufacturers, healthcare agencies, and media partners, serving as a strategic advisor throughout the client lifecycle.
  • Lead onboarding and implementation for new clients, ensuring successful adoption of BranchLab solutions and alignment on business objectives.
  • Partner with clients to define audience strategies, activation plans, success metrics, and measurement approaches.
  • Deliver regular business reviews demonstrating campaign performance, audience insights, and return on investment.
  • Collaborate with Product, Data Science, Operations, and Sales teams to ensure successful execution and continuous client value creation.
  • Identify opportunities to expand client engagement through additional audience solutions, activation channels, analytics capabilities, and offerings.
  • Gather client feedback to inform product roadmap priorities and improve the overall customer experience.
  • Monitor adoption, utilization, retention, and satisfaction metrics while proactively addressing risks and opportunities.
Desired Qualifications
  • Experience supporting pharmaceutical, healthcare, life sciences, or regulated-industry clients.
  • Knowledge of healthcare advertising, media activation, audience targeting, or measurement solutions.
  • Familiarity with programmatic advertising, demand-side platforms, supply-side platforms, data providers, and audience activation workflows.
  • Experience presenting campaign performance, analytics, or business insights to senior stakeholders.
  • Understanding of customer success methodologies, enterprise account management, or strategic consulting.
  • Familiarity with artificial intelligence-driven analytics, predictive modeling, or audience intelligence platforms.

About the company

BranchLab is a data science firm focused on healthcare advertising. It uses artificial intelligence and machine learning to build custom audience models that align with each client’s goals, enabling more precise targeting and better insights for campaigns. The core service helps healthcare brands, their agencies, and TV partners improve return on ad spend while staying compliant with privacy requirements. An ID-less approach keeps consumer health records unlinked from any user ID, prioritizing privacy. BranchLab’s offerings are tailored data solutions that enhance advertising effectiveness and protect personal information, with revenue coming from partnerships with healthcare brands and advertising agencies.

Company Size

51-200

Company Stage

Series A

Total Funding

$26M

Headquarters

New York City, New York

Founded

2024

Get referred to BranchLab

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BranchLab closed a $26 million Series A on May 13, 2026.
  • Dentsu integrated Pathwai on February 11, 2026, expanding distribution across healthcare media.
  • Privacy Updates launched August 19, 2026, covering eight states and weekly expansion.

What critics are saying

  • State privacy rules and HIPAA enforcement threaten Pathwai if de-identified data becomes re-identifiable.
  • BranchLab depends on dentsu and McKesson relationships for revenue momentum.
  • If regulators reject BranchLab's de-identification claims, Pathwai's core model collapses.

What makes BranchLab unique

  • Pathwai turns de-identified health outcomes into demographic audience segments, not raw patient IDs.
  • BranchLab pairs healthcare privacy expertise with AI commercialization tooling and state-law intelligence.
  • McKesson Ventures, Sanofi Ventures, and dentsu validate BranchLab’s platform in 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Hybrid Work Options

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

↑ 31%

1 year growth

↑ 31%

2 year growth

↑ 31%
PR Newswire
Aug 19th, 2026
BranchLab launches privacy tracker to help healthcare marketers navigate US state-by-state regulations

BranchLab has launched Privacy Updates for Marketing Activation, a resource providing state-by-state legal intelligence on how privacy developments affect healthcare advertising and commercialisation. The service initially covers eight US states — California, Connecticut, Illinois, Maryland, New Jersey, New York, Texas, and Washington — selected for their significance to healthcare privacy. Coverage will expand to all 50 states. The resource connects legislation, regulation, enforcement, and case law to healthcare marketing decisions. It builds on BranchLab's Semantic Activation Platform for healthcare commercialisation, where privacy and responsible data use are central features. "Privacy has become one of the defining considerations affecting healthcare commercialisation," said Josh Walsh, chief executive officer of BranchLab. The service is available at the company's website and is provided for informational purposes only.

PR Newswire
May 13th, 2026
BranchLab raises $26M led by McKesson Ventures for AI pharma platform that boosts marketing efficacy 70%

BranchLab, an AI platform for pharmaceutical commercialisation, has raised $26 million in Series A funding led by McKesson Ventures, bringing total funding to $35 million. FCA Venture Partners, Sanofi Ventures and AIX Ventures participated in the round. The Boulder-based company replaces fragmented pharma commercialisation workflows with a unified AI platform that enables real-time patient and healthcare professional audience identification and activation. BranchLab reports its platform has delivered a nearly 70% increase in marketing efficacy across therapeutic areas for pharmaceutical clients. The platform uses a transformer-based architecture that trains models on health data within customer-controlled environments whilst deploying only non-sensitive demographic signals. BranchLab will use the funding to expand enterprise deployments and deepen healthcare ecosystem integrations.

PR Newswire
Feb 11th, 2026
Dentsu partners with BranchLab to use AI for privacy-conscious healthcare audience targeting

Dentsu, a global media and marketing leader, has partnered with BranchLab to integrate the AI company's Pathwai™ platform for healthcare audience targeting. The collaboration transforms dentsu's proprietary data into healthcare-relevant segments anticipated to match or exceed traditional medical claims-based targeting methods. Pathwai™ uses neural networks trained on anonymised health outcomes to create privacy-conscious audience segments for healthcare marketing. The platform enables dentsu to design and activate audiences based on diagnoses, prescriptions and procedures across streaming, programmatic and social media channels. The partnership unlocks new value from dentsu's consumer dataset whilst maintaining HIPAA compliance and state privacy regulations. BranchLab's deep learning architecture translates anonymous patient journeys into targetable segments, with supervised AI learning continuously refining models based on real-world health outcomes.

PR Newswire
Sep 8th, 2025
Next Ventures Invests in BranchLab AI

Next Ventures has announced a strategic investment in BranchLab, an AI-native technology company specializing in privacy-first, outcome-based advertising for healthcare. This investment aims to accelerate AI innovation in precision healthcare by leveraging non-health data to optimize real-world health outcomes. BranchLab's platform, Pathwai™, enables brands to design and measure audiences for healthcare marketing. The partnership aligns with Next Ventures' mission to promote proactive healthcare engagement.

Business Wire
Jun 7th, 2024
BranchLab Launches Privacy-Safe Healthcare Advertising Solution with Seed Funding Round

BranchLab, a data science company developing advanced AI software that enables healthcare brands to reach the right consumers, today announced the clo